GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Other Long Term Assets

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Other Long Term Assets : $0.11 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Other Long Term Assets?

Regencell Bioscience Holdings's other long-term assets for the quarter that ended in Jun. 2023 was $0.11 Mil.

Regencell Bioscience Holdings's quarterly other long-term assets increased from Jun. 2022 ($0.11 Mil) to Dec. 2022 ($1.36 Mil) but then stayed the same from Dec. 2022 ($1.36 Mil) to Jun. 2023 ($0.11 Mil).

Regencell Bioscience Holdings's annual other long-term assets declined from Jun. 2021 ($0.19 Mil) to Jun. 2022 ($0.11 Mil) and declined from Jun. 2022 ($0.11 Mil) to Jun. 2023 ($0.11 Mil).


Regencell Bioscience Holdings Other Long Term Assets Historical Data

The historical data trend for Regencell Bioscience Holdings's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Other Long Term Assets Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Other Long Term Assets
- 0.02 0.19 0.11 0.11

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only 0.19 2.05 0.11 1.36 0.11

Regencell Bioscience Holdings Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Traded in Other Exchanges
N/A
Address
29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Headlines

From GuruFocus